# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001599901-25-000093
Filing Date
2025-04-29
Accepted
2025-04-29 16:04:41
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | a2025schedule14a.htm | DEFA14A | 10432
2 |  | rnanotice-final_pagex1a.jpg | GRAPHIC | 1236963
3 |  | rnanotice-final_pagex2a.jpg | GRAPHIC | 189280
| Complete submission text file | 0001599901-25-000093.txt |  | 1974273

Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39321 | Film No.: 25887074
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)